Risk factors and predictive model for mild cognitive impairment in elderly patients with rheumatoid arthritis

Jun Yan1, Hua Guo1, Lin-Xin Zhang2

  • 1Department of Neurology, Xi'an Fifth Hospital, Xi'an, Shaanxi Province, China.

BMC Rheumatology
|July 2, 2025
PubMed
Abstract

Insights

Longer disease duration, higher inflammation (DAS28, CRP), and osteoporosis increase mild cognitive impairment risk in elderly rheumatoid arthritis patients. A predictive nomogram aids early detection for timely intervention.

Area of Science:

  • Rheumatology
  • Geriatrics
  • Neuroscience

Background:

  • Rheumatoid arthritis (RA) is a chronic autoimmune disease causing joint damage and systemic inflammation, impacting quality of life.
  • Mild cognitive impairment (MCI), a precursor to dementia, is increasingly observed in elderly RA patients.
  • Early identification of MCI in RA patients is crucial for timely interventions to mitigate cognitive decline.

Purpose of the Study:

  • To identify independent risk factors for MCI in elderly RA patients.
  • To develop a predictive nomogram for MCI risk stratification in this population.

Main Methods:

  • 378 elderly RA patients (60-80 years) were assessed for cognitive function using the Montreal Cognitive Assessment (MoCA).
  • MCI was defined as MoCA scores between 20-26.
  • Logistic regression and nomogram construction were used to identify risk factors and predict MCI, with model performance validated by ROC curves, calibration plots, and DCA.

Main Results:

  • 94 out of 378 patients (24.87%) had RA-MCI.
  • Independent risk factors for MCI included longer disease duration (COD), elevated Disease Activity Score-28 (DAS28), high C-reactive protein (CRP) levels, and osteoporosis (OP).
  • The developed nomogram showed moderate predictive discrimination (AUC=0.750).

Conclusions:

  • Disease duration, osteoporosis, DAS28, and CRP levels are significant predictors of MCI in elderly RA patients.
  • The nomogram serves as a practical tool for early risk assessment.
  • Targeted interventions based on this tool can help delay cognitive decline in RA patients.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
70
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.4K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
52
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
41
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
36
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
67